# Safety of an Infant Formula With Hydrolysed Protein in Term Infants

> **NCT04736082** · NA · COMPLETED · sponsor: **HiPP GmbH & Co. Vertrieb KG** · enrollment: 360 (actual)

## Conditions studied

- Growth

## Interventions

- **OTHER:** Intervention Group: Infant Formula with hydrolyzed protein
- **OTHER:** Control Group: Infant Formula with intact protein

## Key facts

- **NCT ID:** NCT04736082
- **Lead sponsor:** HiPP GmbH & Co. Vertrieb KG
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-03-16
- **Primary completion:** 2021-08-31
- **Final completion:** 2021-10-27
- **Target enrollment:** 360 (ACTUAL)
- **Last updated:** 2021-11-26

## Collaborators

- [object Object]
- [object Object]
- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04736082

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04736082, "Safety of an Infant Formula With Hydrolysed Protein in Term Infants". Retrieved via AI Analytics 2026-05-26 from https://api.ai-analytics.org/clinical/NCT04736082. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*